MENU
GILD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Gilead Sciences (GILD) Ownership - Who owns Gilead Sciences?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
18000
Web
https://www.gilead.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
90.79B
P/E Ratio
16.20
Total Cash
7.26B
Projected Growth
0.45
Total Debt
24.99B
Revenue
27.12B
Risk (Beta)
0.33
Dividend Yield
0.04
Total Cash/Share
5.83
Total Debt/Equity
71.31
Revenue/Share
21.55 USD as % of share price
Fundamentals
GILD
Capitalization
90.8B
P/E Ratio
16.20
Risk (Beta)
0.33
Dividend Yield
0.04
Total Cash
7.26B
Total Cash/Share
5.83
Total Debt
25B
Total Debt/Equity
71.31
Projected Growth (PEG Ratio)
0.45
Revenue/Share (as % of the share price)
21.55%
Revenue
27.1B
ROE
N/A
Book Value
22.8B
P/B Ratio
3.98
Cash Flow
N/A
Earnings
4.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1M
Current Ratio
1.43
Current Revenue Per Employee
395222.22
Dividends Per Share - Security
0.75
EBITDA
10.5B
Float
N/A
Float - Current
N/A
Gross Income Margin
70.62
Revenue To Assets
9.04
Shares Held By Institutions
224B
Shares Outstanding - Current
1.25B
Total Liabilities
39.4B
Total Volume MTD
N/A
Value
-1
Gain YTD
19.235
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutic products and treatments for life threatening diseases
Industry PharmaceuticalsMajor
Profile
Fundamentals
Details
Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
18000
Web
https://www.gilead.com